Hmm this is comforting to think about, and what determines it getting pulled from the shelf. I mean im sure there are many things but if they pull all these thats gonna leave alot of people hurting. Unsure of date of this...
FDA Black Box Warning Labels on ADHD Medications
in
ADHD Medication
FDA warnings
After much debate the following medications carry the "black box warnings" on the labels of the bottles. These are the strongest warnings that the FDA requires, a step away from pulling the medications.
Adderall Tablets (mixed salts of a single entity amphetamine product)
Adderall XR (mixed salts of a single entity amphetamine product) Extended-Release Capsules
Concerta (methylphenidate hydrochloride) Extended-Release Tablets
Daytrana (methylphenidate) Transdermal System
Desoxyn (methamphetamine hydrochloride) Tablets Label (will be updated soon)
Dexedrine (dextroamphetamine sulfate) Spansule Capsules and Tablets
Focalin (dexmethylphenidate hydrochloride) Tablets
Focalin XR (dexmethylphenidate hydrochloride) Extended-Release Capsules
Metadate CD (methylphenidate hydrochloride) Extended-Release Capsules
Methylin (methylphenidate hydrochloride) Oral Solution
Methylin (methylphenidate hydrochloride) Chewable Tablets
Ritalin (methylphenidate hydrochloride) Tablets
Ritalin SR (methylphenidate hydrochloride) Sustained-Release Tablets
Ritalin LA (methylphenidate hydrochloride) Extended-Release Capsules
Strattera (atomoxetine hydrochloride) Capsules
Warnings for Amphetamine, Dextroamphetamine, Lisdexamfetamine dismesylate, Methamphetamine, Mixed Salts of a Single Entity Amphetamine Products
Adderall, Adderall XR, Desoxyn, and Dexedrine (SR)
High abuse/diversion potential: Amphetamines have a high potential for abuse. Particular attention should be paid to the possibility of subjects obtaining amphetamines for non-therapeutic use or distribution to others, and the drugs should be prescribed or dispensed sparingly.
Drug dependence: Administration of amphetmaines for prolonged periods of time may lead to drug dependence and must be avoided.
Serious Adverse Events: Misuse of amphetamines may cause sudden death and serious cardiovascular adverse events
Showing posts with label Original Article here: http://newideas.net/adhd/medication/FDA-warnings. Show all posts
Showing posts with label Original Article here: http://newideas.net/adhd/medication/FDA-warnings. Show all posts
Friday, January 11, 2008
Subscribe to:
Posts (Atom)
